Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine

NCT00285402 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine
Migraine Headache
Migraine Disorders
Migraine With Aura
Migraine Without Aura

Interventions

DRUG: AST-726 Low dose
DRUG: AST-726 High dose
DRUG: AST-726 Placebo

Sponsor

Ariston Pharmaceuticals, Inc.